Pulling SEC filings + quote and writing the call…

AMES NATIONAL CORP
Next earnings Jul 16, 2026 · consensus $0.67 EPS
Last earnings -0.4% on 2026-04-24
Cheap Iowa community bank staging a real NIM-driven earnings recovery, but flat balance sheet and volatile history cap it at a hold.
Net income $19.0M · FY2025
Middling fundamentals offset by an attractive price (~237% below fair value) — worth a look on the value angle.
Ames National is a small-cap multi-bank holding company in Iowa whose FY2025 story is a margin-led recovery, not a growth breakout. Net income jumped 86.2% to $19.0M, but the MD&A shows the driver plainly: net interest income rose to $55.7M from $45.0M as interest expense fell to $31.4M (from $37.6M) while interest income climbed to $87.1M. Net interest margin expanded to 2.75% from 2.22%, and the efficiency ratio improved sharply to 62.74% from 76.59%. This is a bank earning its way back after two weak years ($10.8M in 2023, $10.2M in 2024) — the five-year net-income line ($23.9M→$19.3M→$10.8M→$10.2M→$19.0M) still sits below its 2021 peak, so 2025 is best read as normalization rather than a new plateau.
Quality and capital are solid. The equity-to-assets ratio rose to 9.74% (from 8.19%), stockholders' equity grew 19% to $208M, ROE recovered to ~9.95% (MD&A) and credit costs stayed benign at a $1.0M loss expense. Management also cut the dividend payout to 28% (dividends paid down 21.7% to $7.1M), retaining capital and lifting buybacks — a defensible move that shores up the balance sheet. Long-term debt is trivial ($18.4M) and cash grew 25% to $127M. On valuation the stock trades around 1.26x book ($261M market cap vs $208M equity) with a 2.61% yield — inexpensive, but not a screaming bargain for a bank running sub-10% ROE.
Is ATLO a buy? The one-page verdict, explained →
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $23.9M | $19.3M | $10.8M | $10.2M | $19.0M |
| Diluted EPS | $2.62 | — | — | — | — |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Item 8.01 other-event release with exhibit; routine corporate/dividend-type disclosure
Q1 2026: earnings momentum intact as NIM expands off repricing tailwind
Item 5.07: annual-meeting voting results reported; no financial impact
Q1 2026 earnings released; continues NIM-driven recovery from FY2025
Annual proxy: board, pay and auditor for shareholder vote; no financial change
FY2025: net income +86%, NIM 2.75% vs 2.22%, efficiency ratio to 62.7%
Reg FD / other-event release with exhibit; routine dividend/PR-type disclosure
FY2025 results announced: net income $19.0M, up 86% YoY
Item 8.01 other-event release with exhibit; routine dividend/PR disclosure
Sources: SEC EDGAR (CIK 0001132651, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 7/3/2026, 10:44:30 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 6:44 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 4 open-market buys · 0 sales
| 2026-05-29 | Cassabaum Michelle R Director | Buy | 170.00 @ $28.83 | $4.90K |
| 2026-05-15 | Hagan Patrick G Director | Buy | 200.00 @ $27.69 | $5.54K |
| 2026-05-12 | Hagan Patrick G Director | Buy | 100.00 @ $27.65 | $2.77K |
| 2026-04-30 | Cassabaum Michelle R Director | Buy | 84.00 @ $28.08 | $2.36K |
| 2026-02-27 | Cassabaum Michelle R Director | Buy | 205.00 @ $27.25 | $5.59K |
| 2026-01-30 | Cassabaum Michelle R Director | Buy | 280.00 @ $26.11 | $7.31K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median